Breast cancer, a global health concern, presents unique challenges due to its aggressive nature and the difficulty in predicting its progression. This is where the BRIDGE project steps in, aiming to revolutionize our understanding and treatment of this deadly disease.
Unraveling the Mystery of Aggressive Breast Cancer
The World Health Organization's statistics are a stark reminder of the impact of breast cancer, with millions of women affected annually. The focus of this article is on the aggressive forms of the disease, which pose a significant challenge to medical professionals.
The BRIDGE initiative, a collaborative effort between ITQB NOVA and IPOFG, seeks to identify biomarkers that can predict and manage these aggressive cancers. Biomarkers, like biological clues, offer a window into the behavior of cancer cells, guiding treatment decisions.
Studying the Tumor Microenvironment
The project's researchers are delving into the intricate world of the tumor microenvironment, which includes not just cancer cells but also immune cells and supporting structures. Their interest lies in the small molecules on cell surfaces, which may hold the key to understanding how tumors evade detection by the immune system.
Unlocking Tumor-Immune Cell Communication
Catarina Brito, the leader of the Advanced Cell Models laboratory, explains their previous discovery of how tumors communicate with immune cells to protect themselves. With BRIDGE, they aim to validate these findings using real patient samples and translate them into clinical applications. This step is crucial for bridging the gap between laboratory research and practical medical tools.
Towards Personalized Breast Cancer Treatment
By understanding how tumors escape immune attack, researchers hope to develop more precise diagnostic and treatment strategies. The goal is to move away from a one-size-fits-all approach and towards personalized care, where treatments are tailored to the unique characteristics of each patient's cancer.
Funding and Impact
The BRIDGE project, funded by the iNOVA4Health Lighthouse Projects 2025 program, receives up to €75,000 over the next two years. This investment aims to accelerate the development of new strategies to combat aggressive breast cancer, offering hope for improved patient outcomes.
